Biocept Inc.
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor DNA from blood and cerebrospinal fluid, or CSF in the United States. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients … Read more
Market Cap & Net Worth: Biocept Inc. (BIOCQ)
Biocept Inc. (NASDAQ:BIOCQ) has a market capitalization of $262.60 ($262.60) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #49491 globally and #15147 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Biocept Inc.'s stock price $0.00 by its total outstanding shares 2626026 (2.63 Million).
Biocept Inc. Market Cap History: 2015 to 2026
Biocept Inc.'s market capitalization history from 2015 to 2026. Data shows change from $97.85 Billion to $262.60 (-85.84% CAGR).
Biocept Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Biocept Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.61x
Biocept Inc.'s market cap is 1.61 times its annual revenue
0.68x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $228.46 Million | $5.53 Million | -$25.14 Million | 41.32x | N/A |
| 2020 | $349.79 Million | $27.46 Million | -$17.81 Million | 12.74x | N/A |
| 2021 | $285.19 Million | $61.25 Million | -$2.82 Million | 4.66x | N/A |
| 2022 | $41.75 Million | $25.86 Million | -$32.09 Million | 1.61x | N/A |
Competitor Companies of BIOCQ by Market Capitalization
Companies near Biocept Inc. in the global market cap rankings as of March 18, 2026.
Key companies related to Biocept Inc. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #91 globally with a market cap of $176.18 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #154 globally with a market cap of $120.38 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.34 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #512 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #91 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.18 Billion | $470.00 |
| #154 | Danaher Corporation | NYSE:DHR | $120.38 Billion | $191.39 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.34 Billion | $586.37 |
| #512 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Biocept Inc. Historical Marketcap From 2015 to 2026
Between 2015 and today, Biocept Inc.'s market cap moved from $97.85 Billion to $ 262.60, with a yearly change of -85.84%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $262.60 | 0.00% |
| 2025 | $262.60 | 0.00% |
| 2024 | $262.60 | -99.75% |
| 2023 | $105.04K | -99.75% |
| 2022 | $41.75 Million | -85.36% |
| 2021 | $285.19 Million | -18.47% |
| 2020 | $349.79 Million | +53.10% |
| 2019 | $228.46 Million | -66.28% |
| 2018 | $677.51 Million | -95.85% |
| 2017 | $16.31 Billion | -11.54% |
| 2016 | $18.43 Billion | -81.16% |
| 2015 | $97.85 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Biocept Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $262.60 USD |
| MoneyControl | $262.60 USD |
| MarketWatch | $262.60 USD |
| marketcap.company | $262.60 USD |
| Reuters | $262.60 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.